out-licensing and consultancy
As we develop, age, and grow, so do diseases. Today we have diseases without curative treatment; healthcare has to evolve. Introducing novel, patented technologies designed to improve and enhance.
Evolution has led us here….
MEDLAB GROUP PTY LTD was “spun out” of a larger public biotechnology company. Today the principal developers and innovators work collaboratively in commercialising innovating, novel technologies, and formulations that allow partners to modernise healthcare, cosmetic, and nutraceutical offerings.
From patented delivery platforms to specialised formulations for the human microbiome - the goal is the same, unique products that offer our partners a marketable, ethical difference.
With a core focus on chronic illnesses, Medlab offers differentiation and uniqueness with market-ready and near-market-ready products, accompanied by a strong scientific and clinical team allowing for product variations, clinical trials, enhanced development, and market access support.
Together we can make a difference!
In today’s world modern medicine struggles with managing chronic illnesses. New solutions are urgently required. As population impact grows, we are challenged to discover new ways to treat, prevent, and one day cure.
Medlab has several novel patterning assets that have been shown to arrest this development, restore function, quality of life, and revert pre-disease normality to a patient.